P. Dobbin

发表

The influence of chelating agents upon the dissimilatory reduction of Fe(III) by Shewanella putrefaciens

P. Dobbin, A. Powell, A. McEwan, 1995, Biometals.

Characterization of the Shewanella oneidensis MR-1 Decaheme Cytochrome MtrA

P. Dobbin, D. Richardson, A. Thomson, 2003, Journal of Biological Chemistry.

Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy.

P. Dobbin, A. MacRobert, S. Battah, 2006, The international journal of biochemistry & cell biology.

Resonance Raman Spectra of Five-Coordinate Heme-Nitrosyl Cytochromes c': Effect of the Proximal Heme-NO Environment.

P. Dobbin, A. Manole, C. Andrew, 2015, Biochemistry.

Dissimilatory Fe(III) reduction by Clostridium beijerinckii isolated from freshwater sediment using Fe(III) maltol enrichment.

P. Dobbin, A. Powell, D. Richardson, 1999, FEMS microbiology letters.

Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.

P. Dobbin, C. Hershko, A. Pinson, 1991, Blood.

Purification and Magneto-optical Spectroscopic Characterization of Cytoplasmic Membrane and Outer Membrane Multiheme c-Type Cytochromes from Shewanella frigidimarina NCIMB400*

P. Dobbin, D. Richardson, A. Thomson, 2000, The Journal of Biological Chemistry.

Characterization of a flavocytochrome that is induced during the anaerobic respiration of Fe3+ by Shewanella frigidimarina NCIMB400.

P. Dobbin, A. Powell, D. Richardson, 1999, The Biochemical journal.

Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat

M. Barrand, P. Dobbin, R. Hider, 1991, British journal of pharmacology.

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.

D. van der Helm, P. Dobbin, G. Xiao, 1993, Journal of medicinal chemistry.

Dissimilatory iron(III) reduction by Rhodobacter capsulatus.

N. Cook, P. Dobbin, A. Powell, 1996, Microbiology.

The effect of a synthetic hexadentate iron chelator (CP130) and desferrioxamine on rabbit kidneys exposed to cold and warm ischaemia

P. Dobbin, R. Hider, S. Manek, 1993, Agents and Actions.

Structure-stability relationships of 3-hydroxypyridin-4-one complexes

P. Dobbin, D. V. D. Helm, G. Xiao, 1992 .

Synthesis and structure of the N-alkyl-2,6-dimethyl-4-oxopyridine-3-carboxylic acids

P. Dobbin, R. Hider, L. Venkatramani, 1993 .

Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site

G. Brittenham, P. Dobbin, R. Abeysinghe, 1993, British journal of haematology.

The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.

P. Dobbin, C. Hershko, R. Hider, 1991, Blood.

Synthesis, Physicochemical Properties, and Biological Evaluation of N- Substituted 2-Alkyl-3-hydroxy-4(1H)-pyridinones: Orally Active Iron Chelators with Clinical Potential.

P. Dobbin, D. V. D. Helm, G. Xiao, 1994 .

Cytochrome bd confers nitric oxide resistance to Escherichia coli.

C. Cooper, P. Dobbin, P. Nicholls, 2009, Nature chemical biology.

Open conformation of a flavocytochrome c3 fumarate reductase

P. Dobbin, D. Richardson, A. Hemmings, 1999, Nature Structural Biology.

Urinary metabolic profiles in human and rat of 1,2-dimethyl- and 1,2-diethyl-substituted 3-hydroxypyridin-4-ones.

P. Dobbin, R. Hider, S. Singh, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Study of hydrogen bonding in 1-ethyl-2-methyl-4-oxo-1,4-dihydro-pyridin-3-yloxyethanoic acid and 3-(1,2-diethyl-4-oxo-1,4-dihydropyridin-3-yloxy)propanoic acid by 1H NMR spectroscopy and X-ray crystallography

P. Dobbin, R. Hider, S. Rizvi, 1993 .

Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy.

P. Dobbin, R. Hider, A. MacRobert, 2018, Bioconjugate chemistry.

Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy.

P. Dobbin, R. Hider, A. MacRobert, 2017, Journal of medicinal chemistry.

Study of Hydrogen Bonding in 1-Ethyl-2-methyl-4-oxo-1,4-dihydropyridin- 3-yloxyethanoic Acid and 3-(1,2-Diethyl-4-oxo-1,4-dihydropyridin-3- yloxy)propanoic Acid by 1H-NMR Spectroscopy and X-Ray Crystallography

P. Dobbin, R. Hider, S. Rizvi, 1993 .

Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.

P. Dobbin, A. MacRobert, S. Battah, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates

P. Dobbin, A. MacRobert, S. Battah, 2007, Molecular Cancer Therapeutics.

Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study.

P. Dobbin, A. MacRobert, S. Battah, 2006, The international journal of biochemistry & cell biology.

Characterization of Transcriptional Regulation of Shewanella frigidimarina Fe(III)-Induced Flavocytochrome c Reveals a Novel Iron-Responsive Gene Regulation System

G. Sawers, P. Dobbin, D. Richardson, 2003, Journal of bacteriology.

Mechanisms of 5‐aminolevulic acid ester uptake in mammalian cells

Adriana Casas, P. Dobbin, A. MacRobert, 2006, British journal of pharmacology.

Crystallization and preliminary X-ray crystallographic analysis of a periplasmic tetrahaem flavocytochrome c3 from Shewanella frigidimarina NCIMB400 which has fumarate reductase activity.

P. Dobbin, A. Powell, D. Richardson, 1999, Acta crystallographica. Section D, Biological crystallography.

3-[1-(Ethylamino)ethylidene]-6-methyl-3H-pyran-2,4-dione.

D. van der Helm, P. Dobbin, G. Xiao, 1993, Acta crystallographica. Section C, Crystal structure communications.

The influence of chelating agents upon the dissimilatory reduction of Fe(III) byShewanella putrefaciens. Part 2. Oxo-and hydroxo-bridged polynuclear Fe(III) complexes

P. Dobbin, A. Powell, A. McEwan, 1996, Biometals.

Dissociation ofa ferric maltol complex anditssubsequent metabolism during absorption acrossthesmall intestine ofthe rat

P. Dobbin, 1991 .

Voltammetry of a flavocytochrome c(3): the lowest potential heme modulates fumarate reduction rates.

P. Dobbin, D. Richardson, J. Butt, 2000, Biophysical journal.

Conformational control of the binding of diatomic gases to cytochrome c′

P. Dobbin, Michael T. Wilson, A. Manole, 2015, JBIC Journal of Biological Inorganic Chemistry.